Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:TOCA

Tocagen (TOCA) Stock Price, News & Analysis

Tocagen logo

About Tocagen Stock (NASDAQ:TOCA)

Advanced Chart

Key Stats

Today's Range
$9.46
$10.32
50-Day Range
$1.26
$41.03
52-Week Range
$0.42
$6.77
Volume
35,772 shs
Average Volume
1.47 million shs
Market Capitalization
$229.86 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive TOCA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tocagen and its competitors with MarketBeat's FREE daily newsletter.

TOCA Stock News Headlines

Forte Biosciences Inc (FBRX)
Microsoft's Next Big Bet?
Microsoft just broke ground on a revolutionary power system that could deliver virtually limitless, carbon-free energy. Bill Gates calls it “abundant” and is backing four separate startups in the space. While most of these plays are off-limits to everyday investors, a little-known backdoor could give you access to one tiny company leading the charge—and it’s publicly traded.
RiskOn International And 3 Other Stocks Under $2 Insiders Are Buying
See More Headlines

TOCA Stock Analysis - Frequently Asked Questions

Tocagen Inc (NASDAQ:TOCA) issued its earnings results on Thursday, April, 23rd. The company reported ($0.43) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.44) by $0.01. Tocagen had a negative net margin of 176,433.34% and a negative trailing twelve-month return on equity of 327.74%.

Tocagen (TOCA) raised $80 million in an IPO on Thursday, April 13th 2017. The company issued 7,300,000 shares at a price of $10.00-$12.00 per share. Leerink Partners, Evercore ISI and Stifel served as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Tocagen investors own include VBI Vaccines (VBIV), Selecta Biosciences (SELB), Inovio Pharmaceuticals (INO), SCYNEXIS (SCYX), T2 Biosystems (TTOO), Bristol Myers Squibb (BMY) and Catalyst Pharmaceuticals (CPRX).

Company Calendar

Last Earnings
4/23/2020
Today
8/02/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:TOCA
CIK
1419041
Fax
N/A
Employees
77
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($2.69)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$63.52 million
Net Margins
-176,433.34%
Pretax Margin
N/A
Return on Equity
-327.74%
Return on Assets
-111.87%

Debt

Debt-to-Equity Ratio
1.88
Current Ratio
1.15
Quick Ratio
1.15

Sales & Book Value

Annual Sales
$40 thousand
Price / Sales
5,746.54
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.45 per share
Price / Book
21.36

Miscellaneous

Outstanding Shares
23,919,000
Free Float
N/A
Market Cap
$229.86 million
Optionable
Not Optionable
Beta
0.01
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:TOCA) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners